Supported by the Osteosarcoma Institute and Ethos Discovery, the MIMIC trial evaluates a new method of removing lung metastases in dogs, providing insights that can directly inform human osteosarcoma treatment and drug development.
Surviving osteosarcoma at age 10 inspired Hayley Arceneaux’s career caring for children with cancer and opened the door to a history-making mission to space.
The U.S. Food and Drug Administration (FDA), the Osteosarcoma Institute (OSI), and others are coming together to shape the future of osteosarcoma clinical trials.